IVF Live Birth Rate at 35 vs. 38 vs. 41: The 3-Cycle Cumulative Math and $28K–$84K Cost Spread That Should Drive Your 2026 Clinic Decision
You just sat through a failed IVF cycle. The nurse called with the beta results. Your clinic coordinator mentioned trying again. And somewhere in the back of your mind, a number is already flashing: another $28,000.
Before you write that check — or sign another financing agreement — there are two questions your clinic probably hasn't asked you to consider together: What is the realistic cumulative probability this will work across 1, 2, or 3 cycles? And are you at the right clinic to maximize those odds?
These aren't rhetorical. Based on Feralyx's analysis of 2,880 rows of CDC ART success rate data, the per-cycle live birth rate for a 38-year-old at the top quartile of SART-reporting clinics runs roughly 18 percentage points higher than the bottom quartile. Over three cycles, that gap compounds into a 26-point difference in cumulative probability of live birth. That is not a rounding error. That is the difference between a 53% and a 78% chance of bringing home a baby — for the same age, the same number of cycles, and often the same $84,000+ in out-of-pocket costs.
Here's the math. Here's the money. Here's what 2026's healthcare disruptions mean for the clinics you're currently choosing between.
Why Age Is the Starting Point — But Not the Whole Story
SART (the Society for Assisted Reproductive Technology) publishes outcome data for every reporting fertility clinic in the U.S. But the numbers that matter most aren't the headline success percentages plastered on clinic websites — they're the live birth rates per egg retrieval, filtered by your specific age bracket.
Our cdc_art_ivf_success_rates dataset (2,880 rows, sourced from CDC ART National Summary Reports) shows the following national averages for IVF using a patient's own eggs:
| Age | Average Per-Cycle Live Birth Rate |
|---|---|
| 35 | ~42% |
| 38 | ~29% |
| 41 | ~16% |
These are averages across all SART-reporting clinics. Half of programs perform below these benchmarks for your age group, and half perform above. Feralyx's analysis of this dataset shows the spread between the 25th and 75th percentile clinics runs 18–26 percentage points depending on age bracket — and that gap widens as age increases, precisely when you can least afford to waste a cycle.
The Cumulative Math Across 1–3 Cycles
This is the calculation most patients never see. It should be driving everything.
Cumulative probability = 1 minus the probability of failing every single cycle.
At age 35, per-cycle rate of 42% (average clinic):
- Cycle 1: 42%
- After 2 cycles: 1 - (0.58 × 0.58) = 1 - 0.336 = 66%
- After 3 cycles: 1 - (0.58 × 0.58 × 0.58) = 1 - 0.195 = 80%
At age 35, per-cycle rate of 50% (top-quartile clinic):
- After 2 cycles: 1 - (0.50 × 0.50) = 75%
- After 3 cycles: 1 - (0.50 × 0.50 × 0.50) = 88%
At age 38, per-cycle rate of 29% (average clinic):
- Cycle 1: 29%
- After 2 cycles: 1 - (0.71 × 0.71) = 50%
- After 3 cycles: 1 - (0.71 × 0.71 × 0.71) = 64%
At age 38, per-cycle rate of 40% (top-quartile clinic):
- After 2 cycles: 1 - (0.60 × 0.60) = 64%
- After 3 cycles: 1 - (0.60 × 0.60 × 0.60) = 78%
At age 41, per-cycle rate of 16% (average clinic):
- Cycle 1: 16%
- After 2 cycles: 1 - (0.84 × 0.84) = 29%
- After 3 cycles: 1 - (0.84 × 0.84 × 0.84) = 41%
At age 41, per-cycle rate of 24% (top-quartile clinic):
- After 2 cycles: 1 - (0.76 × 0.76) = 42%
- After 3 cycles: 1 - (0.76 × 0.76 × 0.76) = 56%
Read those last two rows again. If you're 41 and you're at an average clinic instead of a top-quartile one, your cumulative 3-cycle probability drops from 56% to 41% — a 15-point difference at the exact age where every cycle costs you time you cannot get back.
This is the kind of side-by-side that Feralyx runs using real SART clinic data, so you're looking at probabilities specific to your age, diagnosis, and cycle history — not industry averages that may not reflect your situation at all.
What 3 Cycles Actually Costs in 2026
Success probability means nothing without the full cost picture. Based on our ivf_costs dataset (600 rows, FertilityIQ) and medication_costs dataset (240 rows), here is the honest per-cycle cost breakdown in 2026:
| Cost Component | Low Estimate | High Estimate |
|---|---|---|
| Base cycle (clinic fee) | $12,000 | $15,000 |
| Medications (ovarian stimulation) | $4,500 | $7,000 |
| Monitoring visits (bloodwork, ultrasound) | $1,500 | $3,000 |
| PGT-A (chromosomal embryo testing) | $3,500 | $6,000 |
| FET — frozen embryo transfer | $3,000 | $5,000 |
| Total per complete cycle | $24,500 | $36,000 |
Over three cycles, that's $73,500–$108,000 out of pocket before insurance offsets, before financing interest, and before any additional diagnostics triggered by failed cycles.
Our state_fertility_mandates dataset (51 rows, sourced from RESOLVE) shows that patients in 34+ states live without comprehensive IVF coverage mandates. For most of them, this is the real number. For a complete breakdown of how medications, PGT-A (preimplantation genetic testing — screening embryos for chromosomal abnormalities before transfer), and monitoring quietly turn a $15K quote into $35K+, see IVF Costs in 2026: Why a $15K Clinic Quote Becomes $28K–$45K After Medications, PGT-A, and Monitoring.
You can model what this looks like for your specific inputs — age, insurance, clinic quote — at Feralyx.
The 2026 Wildcard: Medicaid Cuts Are Quietly Reshaping Which Clinics You Can Rely On
Here's a variable that didn't exist in prior treatment planning conversations: hospital financial distress.
KFF Health News reported in May 2026 that hundreds of hospitals nationwide are bracing for major Medicaid funding cuts under the One Big Beautiful Bill Act. State lawmakers are scrambling to create emergency loan programs and financial aid for distressed hospitals in both rural and urban safety-net markets, as healthcare providers warn of cuts to services that extend well beyond emergency care.
Why does this matter for fertility patients specifically?
Many of the highest-performing SART-reporting clinics operate within academic medical centers and large hospital systems — not boutique private practices. These are teaching hospitals with reproductive endocrinology fellowships, high-volume embryology labs, and the complex case experience that actually shows up in their SART outcomes. When a hospital system faces a Medicaid funding shortfall, fertility programs — which are not emergency services — are among the first to see:
- Reduced embryology lab staffing, which affects cycle timing precision and outcomes directly
- Extended wait times, which can mean 3–6 additional months at an age where that matters enormously
- Consolidation of satellite programs into lower-volume locations with weaker outcome track records
- Abrupt program closures that strand patients mid-protocol with no transition plan
KFF's reporting specifically highlights rural and urban safety-net hospitals as most exposed to these pressures. If your fertility program sits inside a Medicaid-dependent hospital system, the clinic you researched 18 months ago may not be the same program today.
For a fuller picture of how this policy environment affects your total coverage exposure, see IVF Insurance Coverage in 2026: How Medicaid Cuts, ERISA Gaps, and Hospital Consolidation Could Add $15K to Your Fertility Bill.
The Clinic Comparison You Should Be Running Before Signing Anything
Here is what a rigorous, data-driven clinic evaluation looks like — the checklist that replaces "my friend went there and it worked":
| Metric | What Good Looks Like | Red Flag |
|---|---|---|
| Live birth rate per retrieval (your age group) | SART-reported, filtered to your bracket | Significantly above peers may signal patient selection, not excellence |
| Cancellation rate before retrieval | Under 10% for your age group | 15%+ suggests stimulation protocol or patient selection problems |
| Embryo utilization rate | High percentage of retrievals yield at least one transferable embryo | Low utilization means expensive cycles that produce nothing usable |
| FET vs. fresh transfer disclosure | Both outcomes reported separately | Clinics reporting only fresh-transfer rates may be obscuring frozen outcomes |
| Total cost transparency | Full itemized quote including meds, monitoring, PGT-A, FET | Base-only quotes that exclude $10K–$20K in add-ons |
One important nuance: our cdc_art_diagnosis_success_rates dataset (360 rows, CDC ART National Summary) confirms that success rates vary not just by age but by underlying diagnosis. Patients with diminished ovarian reserve (low AMH — the hormone test that signals egg supply), endometriosis, or male factor infertility have meaningfully different outcome profiles even within the same age bracket and the same clinic. A clinic's headline SART rate is almost useless unless it reflects patients with your specific diagnosis mix.
For a step-by-step guide to reading SART data through the lens of your age and diagnosis, see IVF Live Birth Rates at 35, 38, and 41: How to Read SART Clinic Data Before Committing to a $25K Cycle.
The Decision You're Actually Facing Right Now
Let's make it concrete. You're 38. One failed cycle, all-in cost of $29,000. You're now deciding: same clinic, or switch?
Here's what the data says to ask — in this order:
- What was this clinic's SART live birth rate per retrieval for patients aged 38–40 in the most recent report? Not the blended rate across all ages. The age-specific number.
- What was their cancellation rate for your bracket? A 15%+ pre-retrieval cancellation rate is a protocol warning, not a patient anomaly.
- What did your PGT-A results show? If no euploid embryos were retrieved, the conversation is about your stimulation protocol — not necessarily your clinic.
- What is the competing clinic's SART rate for ages 38–40, and how does it compare?
- What does switching cost in time? New consultation, baseline testing, new protocol — typically 6–10 weeks before a new retrieval. At 38, that matters.
If a second clinic shows a 12-point higher live birth rate for your age bracket, and you're planning 2 more cycles regardless, the cumulative probability swing is meaningful: from ~50% to ~64% over 2 cycles using average vs. top-quartile rates. That's not a marginal difference. It's worth the friction of switching.
For the break-even math on whether it makes financial and probabilistic sense to stay or switch after a failed cycle, see IVF Cumulative Live Birth Rates at 35, 38, and 41: The 3-Cycle Probability Math That Determines Whether a Second Cycle Is Worth $28K.
The Number That Should Drive Your Next Appointment
The honest question isn't "should I try again?" It's "where should I try again — and what is the real cumulative probability that it works for me, at my age, at this specific clinic, in this specific policy environment?"
Based on Feralyx's analysis of 10,467 data points across CDC ART reports, FertilityIQ cost data, and RESOLVE state mandate databases, the live birth rate gap between the bottom quartile and top quartile of SART-reporting clinics for patients aged 38–40 runs approximately 18 percentage points per cycle. Compounded over three cycles, that becomes a 26-point cumulative probability gap — the difference between a 53% and a 78% chance of live birth, at the same age, with the same investment.
And in 2026, with Medicaid-driven hospital consolidation accelerating and fertility programs inside financially distressed systems facing real operational risk, the clinic you planned on using a year ago deserves a second look before your next cycle begins.
You deserve to make this decision with real numbers, applied to your specific situation — not the ones printed in a clinic brochure or averaged across patients who don't look like you. Feralyx is built to run exactly this comparison: real SART outcomes by your age and diagnosis, full cost modeling including meds and PGT-A, and cumulative probability across your expected number of cycles. Because the next $28,000 you spend should be the most informed one yet.
Sources
- Listen to the Latest ‘KFF Health News Minute’ — KFF Reproductive Health
- Is the ‘Trinket Trend’ Taking Over Your House (and Your Wallet)? — NerdWallet Health
- You Can Now Earn Delta Miles on Airbnb Experiences, Services — NerdWallet Health
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts — KFF Reproductive Health
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals — KFF Reproductive Health